J. Sebert

发表

Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study

G. Breart, D. Hans, P. Dargent-Molina, 1996, The Lancet.

Destructive spondyloarthropathy in chronic haemodialysis patients. Current data and radiological aspects.

J. Sebert, P. Fardellone, H. Deramond, 1987, Journal of neuroradiology. Journal de neuroradiologie.

Preventing renal bone disease in moderate renal failure with CaCO3 and 25(OH) vitamin D3.

A. Fournier, J. Sebert, J. Guéris, 1988, Kidney international. Supplement.

Monofluorophosphate increases lumbar bone density in osteopenic patients: A double-masked randomized study

J. Sebert, P. Richard, I. Mennecier, 1995, Osteoporosis International.

Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy

P. Delmas, C. Roux, J. Sebert, 2005, Osteoporosis International.

Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?

B. Boudailliez, A. Fournier, J. Sebert, 1992, Bone.

Calcitriol or calcium for postmenopausal osteoporosis.

A. Fournier, J. Sebert, 1992, The New England journal of medicine.

The use of different dual X-ray absorptiometry brands in a multicenter clinical trial: consequences and limits.

J. Reginster, P. Delmas, D. Slosman, 1999, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[Evaluation of the calcium content of diet by frequential self-questionnaire].

J. Sebert, P. Fardellone, G. Leclercq, 1991, Revue du rhumatisme et des maladies osteo-articulaires.

Prevalence and biological consequences of vitamin D deficiency in elderly institutionalized subjects.

M. Maamer, J. Sebert, P. Fardellone, 1995, Revue du rhumatisme.

Urinary excretion of pyridinolines crosslinks measured by immunoassay and HPLC techniques in normal subjects and in elderly patients with vitamin D deficiency.

J. Sebert, S. Kamel, M. Brazier, 1994, Bone and mineral.

Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients.

B. Boudailliez, R. Bouillon, A. Fournier, 1991, The Journal of clinical endocrinology and metabolism.

Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.

A. Fournier, J. Sebert, P. Bordier, 1979, Kidney international.

Effect of thyrotoxicosis and its treatment on mineral and bone metabolism

A. Fournier, J. Sebert, J. Lalau, 1986, Journal of endocrinological investigation.

Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.

A. Fournier, J. Sebert, J. Guéris, 1986, Kidney international. Supplement.

Adynamic bone disease in uremia: may it be idiopathic? Is it an actual disease?

B. Boudailliez, J. Achard, A. Fournier, 1991, Nephron.

Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum.

B. Boudailliez, P. Fiévet, J. Sebert, 1989, Nephron.

Comparative effects of dialysis with cuprophan versus polyacrylonitrile membranes on plasma immunoreactive parathyroid hormone levels in patients on chronic hemodialysis

A. Fournier, J. Sebert, J. Guéris, 1976, Calcified Tissue Research.

Two new cancer locations accompanied with palmar fasciitis and polyarthritis.

J. Sebert, F. Grados, P. Fardellone, 1998, Revue du rhumatisme.

Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake.

J. Sebert, P. Fardellone, S. Kamel, 1998, Clinical chemistry.

Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial.

D O Slosman, J. Reginster, P. Delmas, 2002, The Journal of clinical endocrinology and metabolism.

Destructive spondylarthropathy in hemodialyzed patients: possible role of amyloidosis.

A. Fournier, G. Lambrey, J. Sebert, 1986, Arthritis and rheumatism.

Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis.

A. Fournier, J. Sebert, P. Fardellone, 1991, Nephron.

Renal osteodystrophy: pathophysiology and treatment.

A. Fournier, J. Sebert, P. Morinière, 1984, Hormone research.

[Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?].

A. Fournier, G. Lambrey, J. Sebert, 1982, Nephrologie.

Influence of Age and Sex on Vertebral Shape Indices Assessed by Radiographic Morphometry

C. Roux, J. Sebert, F. Grados, 1999, Osteoporosis International.

Effects of oral cimetidine on parathyroid hormone and calcitonin plasma levels in uremic patients.

A. Fournier, M. Andréjak, J. Sebert, 1982, Advances in experimental medicine and biology.

Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.

A. Fournier, J. Sebert, J. Guéris, 1985, Nephron.

Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patients.

A. Fournier, J. Sebert, P. Fardellone, 1987, Bone and mineral.

How Hip and Whole-Body Bone Mineral Density Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study

D. Hans, P. Dargent-Molina, A. Schott, 1998, Osteoporosis International.

Fluoride Salts are no Better at Preventing New Vertebral Fractures than Calcium-Vitamin D in Postmenopausal Osteoporosis: The FAVOStudy

J. Reginster, X. Marchandise, T. Appelboom, 1998, Osteoporosis International.

A simple and automated HPLC method for determination of total hydroxyproline in urine. Comparison with excretion of pyridinolines.

S. Castelain, J. Sebert, S. Kamel, 1995, Clinica chimica acta; international journal of clinical chemistry.

Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake.

J. Sebert, P. Fardellone, J. Guéris, 1998, The American journal of clinical nutrition.

Possible link between changes in plasma 24,25-dihydroxyvitamin D and healing of bone resorption in dialysis osteodystrophy.

A. Fournier, G. Lambrey, P. Meunier, 1982, Metabolic bone disease & related research.

Renal Osteodystrophy: General Concepts and Current Issues

B. Boudailliez, P. Meunier, J. Sebert, 1984 .

Comparison of Four Morphometric Definitions and a Semiquantitative Consensus Reading for Assessing Prevalent Vertebral Fractures

C. Roux, J. Sebert, F. Grados, 2001, Osteoporosis International.

Limit by hypherphosphatemia ofthe usefulness of vitamin D metabolites (1α-hydroxycholecalciferol and 25-hydroxycholecalciferol) in the treatment of renal osteodystrophy

A. Fournier, G. Lambrey, P. Meunier, 1980 .

Strontium ranelate : dose-dependent effects in postmenopausal osteoporosis : the STRATOS 2-year randomised trial

J. Reginster, P. Delmas, D. Slosman, 2001 .

Strontium ranelate as a treatment of vertebral osteoporosis

J. Reginster, P. Delmas, C. Albanese, 1997 .

The strontium salt S-12911: A new candidate for the treatment of osteoporosis

J. Reginster, C. Albanese, D. Slosman, 2006, Osteoporosis International.

Erosive osteoarthropathy associated with beta 2-microglobulin amyloidosis in a uraemic patient treated exclusively by long-term haemofiltration with biocompatible membranes.

A. Fournier, J. Sebert, P. Morinière, 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Long-term stability of bone mineral density in patients with renal transplant treated with cyclosporine and low doses of corticoids. Protective role of cyclosporine?].

A. Fournier, H. Mazouz, J. Sebert, 1998, Presse medicale.

Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial.

J. Reginster, P. Delmas, D. Slosman, 2002, The Journal of clinical endocrinology and metabolism.

Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremia.

A. Fournier, M. Andréjak, J. Sebert, 1982, Advances in experimental medicine and biology.

Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients.

C. Desplan, A. Fournier, M. Andréjak, 1980, British medical journal.